Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

PathsToDormancy: Identifying dormancy pathways for selective targeting

Project description

In vitro dormancy culture systems for cancer treatment

The survival and reproduction of species depend on regulating cellular growth and dormancy, which are essential for reproduction, regeneration, and repair. Mechanisms like embryonic diapause allow organisms to pause development. During dormancy, embryonic cells undergo changes in their transcriptional, epigenetic, and metabolic pathways, preserving their stem cell characteristics for reactivation when conditions improve. However, dormancy poses challenges in cancer treatment, as cancer cells exploit these pathways to become drug-tolerant persister (DTP) cells, potentially leading to more aggressive relapses. This complicates efforts to target dormant cancer cells. The ERC-funded PathsToDormancy project will use in vitro dormancy culture systems to identify regulators of cancer dormancy with embryonic origins.

Objective

The survival and propagation of species fundamentally depend on the precise regulation of cellular growth and dormancy. This balance is crucial across various biological processes including reproduction, regeneration, and repair, where mechanisms such as embryonic diapause allow organisms to endure adverse conditions by temporarily halting development. During this dormant state, embryonic cells undergo significant rewiring of their transcriptional, epigenetic, and metabolic pathways, preserving their stem cell characteristics and enabling reactivation under more favorable conditions. Despite its essential role, dormancy presents challenges in cancer treatment. Cancer cells exploit conserved dormancy pathways to evade therapies, resulting in drug-tolerant persister (DTP) cells that can survive treatment, potentially leading to relapse with more aggressive and metastatic tumors. This phenomenon undermines efforts to combat cancer, as detecting and targeting dormant cancer cells remains a significant obstacle. Here we will leverage our in vitro dormancy culture systems identify regulators of cancer dormancy with embryonic origin.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2024-POC

See all projects funded under this call

Host institution

MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV
Net EU contribution
€ 150 000,00
Address
HOFGARTENSTRASSE 8
80539 MUNCHEN
Germany
Region
Berlin Berlin Berlin
Activity type
Research Organisations
Links
Total cost
No data

Beneficiaries (1)